Cerebral blood flow regulation

8 min read Last updated April 8, 2026

Core equations and key numbers

  • CBF is driven by cerebral perfusion pressure (CPP) and opposed by cerebrovascular resistance (CVR): CBF ≈ CPP / CVR
    • CPP = MAP − ICP (or MAP − CVP if CVP > ICP).
    • Normal global CBF: ~50 mL/100 g/min (≈ 700–800 mL/min). Grey matter higher than white matter.
    • Normal ICP: ~5–15 mmHg (adult).
  • Cerebral metabolic rate for oxygen: CMRO2 ~3–3.5 mL O2/100 g/min; coupling between flow and metabolism is central to regulation.
  • Critical flow thresholds (approximate): electrical failure ~20 mL/100 g/min; membrane failure/infarction ~10 mL/100 g/min (time-dependent).

How to think at the bedside (MAP/ICP/CO2/O2/temperature)

  • If ICP rises: CPP falls unless MAP rises; autoregulation may be impaired in injury → CBF becomes pressure-passive.
    • Treatables: optimise venous drainage (head-up, neutral neck), avoid hypercapnia/hypoxia, control agitation/fever, consider hyperosmolar therapy as indicated.
  • CO2 is a powerful, rapid modulator: hypercapnia → vasodilation ↑CBF ↑CBV ↑ICP; hypocapnia → vasoconstriction ↓CBF ↓CBV ↓ICP (risk ischaemia).
  • O2 has little effect until PaO2 is low: PaO2 < ~50 mmHg → marked vasodilation ↑CBF (often with raised ICP). Hyperoxia has small/variable vasoconstriction.
  • Temperature and metabolism: fever ↑CMRO2 and tends to ↑CBF; hypothermia ↓CMRO2 and tends to ↓CBF (protective in selected contexts).

Determinants of CBF: pressure, resistance, and vessel calibre

  • CBF depends on CPP and CVR; CVR is strongly influenced by arteriolar radius (Poiseuille relationship: resistance ∝ 1/r^4).
  • Cerebral blood volume (CBV) matters for ICP: venous capacitance and arterial tone changes can alter CBV and therefore ICP.
  • Blood viscosity: ↑haematocrit increases viscosity (tends to ↓CBF) but increases O2 content; anaemia lowers viscosity (tends to ↑CBF) but reduces O2 content.
    • Net oxygen delivery to brain depends on CBF × arterial O2 content; compensatory CBF rise in anaemia may be limited in injury.

Autoregulation (pressure reactivity)

  • Definition: ability to maintain relatively constant CBF over a range of CPP by adjusting arteriolar tone.
  • Classical curve: plateau over MAP/CPP range (often quoted MAP ~60–150 mmHg in healthy adults), with pressure-passive flow outside this range.
    • Chronic hypertension shifts the curve rightward (higher lower limit).
    • In neonates/elderly/brain-injured patients, plateau may be narrower or absent.
  • Mechanisms: myogenic (stretch-induced constriction/dilation), metabolic (local CO2/H+/adenosine/K+), and neurogenic/endothelial (NO, prostanoids).
  • Dynamic autoregulation occurs over seconds; static autoregulation refers to steady-state changes over minutes.
  • Autoregulation is commonly impaired by: traumatic brain injury, subarachnoid haemorrhage, stroke/ischemia, severe sepsis, hypercapnia, volatile anaesthetics (dose-dependent).

CO2 reactivity (chemical control via PaCO2 / pH)

  • Primary mediator is extracellular pH in/around cerebral arterioles (CO2 diffuses across BBB → carbonic acid → H+).
  • Magnitude: CBF changes roughly ~2–4% per 1 mmHg change in PaCO2 (commonly taught ~3%/mmHg) within PaCO2 ~20–80 mmHg.
  • Clinical implications: hyperventilation reduces CBF/CBV/ICP quickly, but effect attenuates over 6–24 h due to CSF HCO3− buffering; abrupt cessation can cause rebound hyperaemia/ICP rise.
    • Avoid prolonged profound hypocapnia (risk cerebral ischaemia), especially after TBI and in focal lesions where steal may occur.

O2 reactivity

  • PaO2 has minimal effect on CBF until significant hypoxaemia; below ~50 mmHg CBF rises steeply (vasodilation).
  • Mechanisms include adenosine, NO, and KATP channel effects; hypoxia often coexists with hypercapnia which amplifies vasodilation.
  • Hyperoxia: small reduction in CBF may occur; clinical relevance is context-dependent (e.g., after SAH or post-cardiac arrest strategies).

Neurovascular coupling (flow–metabolism coupling)

  • Increased neuronal activity → increased CMRO2 and glucose use → local vasodilation and increased regional CBF (functional hyperaemia).
  • Mediators: glutamate signalling via astrocytes, NO, prostaglandins, adenosine, K+; ensures supply matches demand.
  • Clinical: seizures markedly increase CMRO2 and CBF; deep anaesthesia and hypothermia reduce CMRO2 and usually reduce CBF.

Sympathetic/parasympathetic influences

  • Cerebral vessels have sympathetic innervation; effect is modest under normal conditions but may protect against hyperperfusion at high MAP (limits forced dilation).
  • Parasympathetic and sensory fibres can influence tone via NO and neuropeptides; overall metabolic/chemical control predominates.

Effects of anaesthetic drugs and ventilation on CBF regulation

  • Volatile agents: dose-dependent cerebral vasodilation (↑CBF, ↑CBV, ↑ICP) while reducing CMRO2; at higher MAC, vasodilation predominates and autoregulation is impaired.
    • CO2 reactivity is generally preserved with volatiles but may be blunted at high doses.
  • IV agents (propofol, thiopentone): reduce CMRO2 and typically reduce CBF and ICP; preserve autoregulation and CO2 reactivity relatively well.
  • Ketamine: historically thought to increase CBF/ICP; with controlled ventilation and co-administered GABAergic anaesthesia, ICP effects are often minimal; still consider context (obstructed CSF pathways, severe intracranial hypertension).
  • Opioids: minimal direct effect on CBF; secondary effects via PaCO2 (hypoventilation → hypercapnia → ↑CBF/ICP).
  • N2O: increases CBF/CMRO2 and can increase ICP; avoid in raised ICP or where intracranial compliance is poor.

Pathophysiology: when regulation fails

  • Pressure-passive flow: impaired autoregulation → CBF varies directly with CPP; hypotension risks ischaemia, hypertension risks hyperaemia/oedema/haemorrhage.
  • Steal phenomena: in regions with maximally dilated arterioles (ischaemic penumbra), vasodilation elsewhere (e.g., hypercapnia, volatiles) can divert flow away (intracerebral steal).
  • Inverse steal (Robin Hood): hypocapnia can preferentially constrict normal vessels and may improve flow to ischaemic areas in some settings, but global CBF reduction can worsen ischaemia—unreliable clinically.
Define cerebral perfusion pressure and explain how it relates to cerebral blood flow.

A common physiology viva: start with definitions, then apply clinically (e.g., raised ICP).

  • CPP = MAP − ICP (or MAP − CVP if CVP exceeds ICP).
  • CBF is approximately CBF ≈ CPP / CVR; thus CBF depends on both driving pressure and arteriolar resistance.
  • If autoregulation intact, CBF is relatively constant across a CPP range; if impaired, CBF becomes pressure-passive.
  • Clinical application: raised ICP reduces CPP; treatment aims to lower ICP and/or support MAP while avoiding factors that increase CBV (hypercapnia, hypoxia).
Describe cerebral autoregulation and factors that shift or impair it.
  • Autoregulation: intrinsic ability to keep CBF relatively constant by changing arteriolar tone in response to CPP changes.
  • Classical plateau often quoted between MAP ~60–150 mmHg in healthy adults (variable between individuals).
  • Curve shifts: chronic hypertension → right shift (higher lower limit); hypotension/vasodilator states may reduce reserve.
  • Impaired by: TBI, SAH, stroke/ischemia, severe sepsis, hypercapnia, high-dose volatile anaesthetics.
Explain the effect of PaCO2 on CBF and how you would use this in managing raised ICP.
  • CBF changes about ~2–4% per 1 mmHg change in PaCO2 (within ~20–80 mmHg).
  • Mechanism: CO2 diffuses across BBB → changes perivascular pH → arteriolar dilation (hypercapnia) or constriction (hypocapnia).
  • Hyperventilation: ↓PaCO2 → ↓CBF and ↓CBV → ↓ICP quickly; use as a short-term temporising measure (e.g., impending herniation).
  • Limitations: effect attenuates over hours due to CSF bicarbonate buffering; excessive hypocapnia risks cerebral ischaemia and may worsen outcome after TBI if prolonged.
What is the effect of hypoxaemia on CBF? Give a threshold and mechanism.
  • PaO2 has little effect until ~50 mmHg; below this, CBF increases steeply due to vasodilation.
  • Mediators include adenosine, NO, KATP channels; concurrent hypercapnia amplifies the response.
  • Clinical: hypoxia can raise ICP (via increased CBF/CBV) and must be corrected promptly.
How do volatile and intravenous anaesthetics affect CBF, CMRO2, autoregulation and CO2 reactivity?
  • Volatiles: ↓CMRO2 but vasodilate cerebral vessels → ↑CBF/CBV/ICP; at higher MAC, autoregulation becomes impaired.
  • IV agents (propofol/thiopentone): ↓CMRO2 and usually ↓CBF and ↓ICP; autoregulation and CO2 reactivity relatively preserved.
  • N2O increases CBF/CMRO2 and can increase ICP; avoid when compliance is poor.
  • Opioids: little direct effect; hypoventilation → hypercapnia → ↑CBF/ICP.
A previous-style viva: 'Explain the relationship between CBF, CBV and ICP, and how ventilation changes ICP.'
  • CBV contributes to intracranial volume; with limited compliance, increases in CBV raise ICP (Monro–Kellie doctrine context).
  • PaCO2 changes arteriolar calibre → changes CBV: hypercapnia increases CBV and ICP; hypocapnia reduces CBV and ICP.
  • Ventilation strategy: aim normocapnia routinely; use brief mild hypocapnia only for acute ICP crises while definitive measures are instituted.
Discuss the effect of systemic blood pressure changes on CBF in (a) normal brain and (b) traumatic brain injury.
  • Normal: autoregulation buffers CBF across a CPP range; outside limits, CBF becomes pressure-dependent.
  • TBI: autoregulation often impaired → CBF pressure-passive; hypotension can cause ischaemia; hypertension can worsen oedema/haemorrhage and raise ICP via hyperaemia.
  • Management implication: target adequate CPP (institutional targets vary), avoid hypotension, treat raised ICP, and individualise MAP goals (e.g., based on pressure reactivity monitoring where available).
What is neurovascular coupling and give clinical examples where it is important?
  • Neurovascular coupling: local neuronal activity increases local CBF to match metabolic demand (functional hyperaemia).
  • Examples: seizures (↑CMRO2 and ↑CBF), pain/agitation/fever (↑metabolic demand), deep anaesthesia/hypothermia (↓CMRO2 and ↓CBF).
  • In injured brain, coupling may be disrupted, so normal assumptions about flow-metabolism matching may fail.
Explain 'cerebral steal' and how CO2 and volatile agents can influence it.
  • In ischaemic regions arterioles may already be maximally dilated; further vasodilation cannot occur locally.
  • If other regions vasodilate (hypercapnia, volatile anaesthetics), resistance falls there and flow is diverted away from the ischaemic territory → steal.
  • Clinical implication: avoid unnecessary hypercapnia and excessive volatile concentrations in patients with focal cerebrovascular disease; maintain stable CPP and normocapnia.

0 comments